9 results on '"Schirmer, Stephan H."'
Search Results
2. Atrial Remodeling Following Catheter-Based Renal Denervation Occurs in a Blood Pressure- and Heart Rate-Independent Manner.
- Author
-
Schirmer SH, Sayed MM, Reil JC, Lavall D, Ukena C, Linz D, Mahfoud F, and Böhm M
- Subjects
- Aged, Antihypertensive Agents therapeutic use, Atrial Premature Complexes etiology, Atrial Premature Complexes physiopathology, Catheter Ablation adverse effects, Drug Resistance, Female, Germany, Humans, Hypertension complications, Hypertension diagnosis, Hypertension physiopathology, Male, Middle Aged, Prospective Studies, Sympathectomy adverse effects, Time Factors, Treatment Outcome, Atrial Function, Left, Atrial Premature Complexes prevention & control, Atrial Remodeling, Blood Pressure drug effects, Heart Rate, Hypertension surgery, Kidney blood supply, Renal Artery innervation, Sympathectomy methods
- Abstract
Objectives: This study sought to investigate left atrial (LA) remodeling in relation to blood pressure (BP) and heart rate (HR) after renal sympathetic denervation (RDN)., Background: In addition to reducing BP and HR in certain patients with hypertension, RDN can decrease left ventricular (LV) mass and ameliorate LV diastolic dysfunction., Methods: Before and 6 months after RDN, BP, HR, LV mass, left atrial volume index (LAVI), diastolic function (echocardiography), and premature atrial contractions (PAC) (Holter electrocardiogram) were assessed in 66 patients with resistant hypertension., Results: RDN reduced office BP by 21.6 ± 3.0/10.1 ± 2.0 mm Hg (p < 0.001), and HR by 8.0 ± 1.3 beats/min (p < 0.001). At baseline, LA size correlated with LV mass, diastolic function, and pro-brain natriuretic peptide, but not with BP or HR. Six months after RDN, LAVI was reduced by 4.0 ± 0.7 ml/kg/m(2) (p < 0.001). LA size decrease was stronger when LAVI at baseline was higher. In contrast, the decrease in LAVI was not dependent on LV mass or diastolic function (E/E' or E/A) at baseline. Furthermore, LAVI decreased without relation to decrease in systolic BP or HR. Additionally, occurrence of PAC (median of >153 PAC/24 h) was reduced (to 68 PAC/24 h) by RDN, independently of changes in LA size., Conclusions: In patients with resistant hypertension, LA volume and occurrence of PAC decreased 6 months after RDN. This decrease was independent of BP and HR at baseline or the reduction in BP and HR reached by renal denervation. These data suggest that there is a direct, partly BP-independent effect of RDN on cardiac remodeling and occurrence of premature atrial contractions., (Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
3. Renal nerve ablation.
- Author
-
Donazzan L, Mahfoud F, Schirmer SH, and Böhm M
- Subjects
- Humans, Hypertension diagnosis, Hypertension physiopathology, Patient Selection, Risk Factors, Sympathectomy adverse effects, Treatment Outcome, Blood Pressure, Catheter Ablation adverse effects, Hypertension surgery, Kidney innervation, Sympathectomy methods
- Published
- 2015
- Full Text
- View/download PDF
4. Effect of obstructive respiratory events on blood pressure and renal perfusion in a pig model for sleep apnea.
- Author
-
Linz D, Mahfoud F, Linz B, Hohl M, Schirmer SH, Wirth KJ, and Böhm M
- Subjects
- Aldosterone blood, Animals, Antihypertensive Agents pharmacology, Biphenyl Compounds pharmacology, Blood Pressure drug effects, Creatinine urine, Disease Models, Animal, Hypertension complications, Irbesartan, Kidney drug effects, Kidney innervation, Proteinuria, Renal Artery drug effects, Renal Artery physiopathology, Renin blood, Sleep Apnea, Obstructive complications, Tetrazoles pharmacology, Blood Pressure physiology, Hypertension physiopathology, Kidney blood supply, Sleep Apnea, Obstructive physiopathology, Sympathectomy
- Abstract
Background: Obstructive sleep apnea (OSA) is associated with hypertension and the progression of chronic kidney disease (CKD). Renal sympathetic innervation contributes to either condition., Methods: We investigated the effect of renal sympathetic denervation (RDN) on blood pressure (BP), renal perfusion, and neurohumoral responses during and after repetitive obstructive apneas in a pig model for OSA. BP, femoral artery, and renal artery flow were measured in 29 spontaneously breathing urethane-chloralose-anesthetized pigs. The effect of RDN (n = 14) and irbesartan (n = 3) was investigated. Repetitive tracheal occlusions for 2 minutes with applied negative tracheal pressure at -80 mbar were performed over 4 hours., Results: Spontaneous breathing attempts during tracheal occlusion caused an intra-apneic breathing synchronous oscillating pattern of renal flow. Renal flow oscillations were > 2-fold higher compared with femoral flow that almost showed changes proportional to the BP alterations (2.9%/mm Hg vs. 1.3%/mm Hg; P < 0.0001). A marked postapneic BP rise from 102 ± 3 to 172 ± 8 mm Hg (P < 0.00001) was associated with renal hypoperfusion (from 190 ± 24 to 70 ± 20 ml/min; P < 0.00001) occurring after application of obstructive respiratory events. RDN, but not irbesartan, inhibited postapneic BP rises and renal hypoperfusion and attenuated increased plasma renin activity and aldosterone concentration induced by repetitive tracheal occlusions. Additionally, increased urinary protein/creatinine ratio was significantly reduced by RDN, whereas intra-apneic hemodynamic changes or blood gases were not modified by RDN., Conclusions: Repetitive obstructive respiratory events result in postapneic BP rises and renal hypoperfusion, as well as neurohumoral responses and increased protein/creatinine ratio. These changes are mainly sympathetically driven because they could be attenuated by RDN., (© American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2014
- Full Text
- View/download PDF
5. Renal denervation: effects on atrial electrophysiology and arrhythmias.
- Author
-
Linz D, van Hunnik A, Ukena C, Ewen S, Mahfoud F, Schirmer SH, Lenski M, Neuberger HR, Schotten U, and Böhm M
- Subjects
- Animals, Evidence-Based Medicine, Heart Failure prevention & control, Humans, Hypertension prevention & control, Renal Artery surgery, Sleep Apnea Syndromes prevention & control, Treatment Outcome, Atrial Fibrillation physiopathology, Atrial Fibrillation surgery, Heart Failure physiopathology, Hypertension physiopathology, Renal Artery innervation, Sleep Apnea Syndromes physiopathology, Sympathectomy methods
- Abstract
Atrial fibrillation (AF) is the most common sustained arrhythmia and is associated with significant morbidity and mortality. Currently, atrial endocardial catheter ablation, mainly targeting focal discharges in the pulmonary veins, is the most widely used interventional treatment of drug-refractory AF. Despite technical improvements, results are not yet optimal. There is ongoing search for alternative and/or complementary interventional targets. Conditions associated with increased sympathetic activation such as hypertension, heart failure and sleep apnea lead to structural, neural and electrophysiological changes in the atrium thereby contributing to the progression from paroxysmal to persistent AF and increasing recurrence rate of AF after PVI. Until now, interventional modulation of autonomic nervous system was limited by highly invasive techniques. Catheter-based renal denervation (RDN) was introduced as a minimally invasive approach to reduce renal and whole body sympathetic activation with accompanying blood pressure control and left-ventricular morphological and functional changes in resistant hypertension. This review focuses on the potential atrial antiarrhythmic and antiremodeling effects of RDN in AF patients with hypertension, heart failure, and sleep apnea and discusses the possible role of RDN in the treatment of AF.
- Published
- 2014
- Full Text
- View/download PDF
6. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension.
- Author
-
Brandt MC, Mahfoud F, Reda S, Schirmer SH, Erdmann E, Böhm M, and Hoppe UC
- Subjects
- Blood Pressure, Diastole, Echocardiography, Female, Follow-Up Studies, Heart Ventricles diagnostic imaging, Humans, Hypertension physiopathology, Hypertension therapy, Hypertrophy, Left Ventricular etiology, Hypertrophy, Left Ventricular physiopathology, Male, Middle Aged, Renal Artery innervation, Retrospective Studies, Systole, Treatment Outcome, Heart Ventricles physiopathology, Hypertension complications, Hypertrophy, Left Ventricular therapy, Kidney innervation, Sympathectomy methods, Ventricular Function, Left physiology
- Abstract
Objectives: This study investigated the effect of catheter-based renal sympathetic denervation (RD) on left ventricular hypertrophy (LVH) and systolic and diastolic function in patients with resistant hypertension., Background: LVH and diastolic dysfunction are associated with elevated sympathetic activity and increased morbidity and mortality. The effect of RD on LVH and LV function is unclear., Methods: Forty-six patients underwent bilateral RD, and 18 patients served as controls. Transthoracic echocardiography was performed at baseline, and after 1 month and 6 months., Results: Besides reduction of systolic and diastolic blood pressure (-22.5/-7.2 mm Hg at 1 month and -27.8/-8.8 mm Hg at 6 months, p < 0.001 at each time point), RD significantly reduced mean interventricular septum thickness from 14.1 ± 1.9 mm to 13.4 ± 2.1 mm and 12.5 ± 1.4 mm (p = 0.007), and LV mass index from 53.9 ± 15.6 g/m(2.7) (112.4 ± 33.9 g/m(2)) to 47.0 ± 14.2 g/m(2.7) (103.6 ± 30.5 g/m(2)) and 44.7 ± 14.9 g/m(2.7) (94.9 ± 29.8 g/m(2)) (p < 0.001) at 1 month and 6 months, respectively. The mitral valve lateral E/E' decreased after RD from 9.9 ± 4.0 to 7.9 ± 2.2 at 1 month and 7.4 ± 2.7 at 6 months (p < 0.001), indicating reduction of LV filling pressures. Isovolumic relaxation time shortened (baseline 109.1 ± 21.7 ms vs. 85.6 ± 24.4 ms at 6 months, p = 0.006), whereas ejection fraction significantly increased after RD (baseline: 63.1 ± 8.1% vs. 70.1 ± 11.5% at 6 months, p < 0.001). No significant changes were obtained in control patients., Conclusions: Besides the known effect on blood pressure, our study showed for the first time that RD significantly reduces LV mass and improves diastolic function, which might have important prognostic implications in patients with resistant hypertension at high cardiovascular risk., (Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
7. Kardiovaskuläre Therapie bei chronischer Nierenerkrankung
- Author
-
Brandenburg, Vincent, Saritas, Turgay, Schirmer, Stephan H., Rogacev, Kyrill, and Heine, Gunnar Henrik
- Published
- 2023
- Full Text
- View/download PDF
8. Improvements in Left Ventricular Hypertrophy and Diastolic Function Following Renal Denervation: Effects Beyond Blood Pressure and Heart Rate Reduction.
- Author
-
Schirmer, Stephan H., Sayed, Marwa M.Y.A., Reil, Jan-Christian, Ukena, Christian, Linz, Dominik, Kindermann, Michael, Laufs, Ulrich, Mahfoud, Felix, and Böhm, Michael
- Subjects
- *
HYPERTROPHY , *DIASTOLE (Cardiac cycle) , *KIDNEY surgery , *DENERVATION , *BLOOD pressure , *HEART beat , *LEFT heart ventricle , *HYPERTENSION - Abstract
Objectives: This study sought to investigate the interaction between blood pressure (BP) and heart rate (HR) reduction and changes in left ventricular (LV) structure and function following renal sympathetic denervation (RDN). Background: Hypertension results in structural and functional cardiac changes. RDN reduces BP, HR, and LV mass and improves diastolic dysfunction. Methods: We evaluated LV size, mass, and function before and 6 months after RDN in 66 patients with resistant hypertension and analyzed results in relation to systolic BP (SBP) and HR. Results: SBP decreased by 11 ± 3 mm Hg in the first, 18 ± 5 mm Hg in the second, and 36 ± 7 mm Hg in the third tertile of SBP at baseline (p < 0.001). HR decreased by 13 ± 4 beats/min, 8 ± 3 beats/min, and 11 ± 6 beats/min in tertiles of SBP (p for interaction between tertiles = 0.314). In all SBP tertiles, LV mass index (LVMI) decreased similarly (LVMI −6.3 ± 2.2 g/m2.7, −8.3 ± 2.1 g/m2.7, and −9.6 ± 1.9 g/m2.7; p for interaction = 0.639). LVMI decreased unrelated to HR at baseline (p for interaction = 0.471). The diastolic parameters E-wave deceleration time, isovolumetric relaxation time, and E′-wave velocity improved similarly in all tertiles of SBP and HR. Changes in LV mass and function were also unrelated to reduction in SBP or HR. Vascular compliance improved dependently on BP but independently of HR reduction. Conclusions: In patients with resistant hypertension, LV hypertrophy and diastolic function improved 6 months after RDN, without significant relation to SBP and HR. These findings suggest a direct effect of altered sympathetic activity in addition to unloading on cardiac hypertrophy and function. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
9. Vascular Pathophysiology in Response to Increased Heart Rate
- Author
-
Custodis, Florian, Schirmer, Stephan H., Baumhäkel, Magnus, Heusch, Gerd, Böhm, Michael, and Laufs, Ulrich
- Subjects
- *
CARDIOVASCULAR diseases , *PATIENTS , *PATHOLOGICAL physiology , *HEART beat , *HYPERTENSION , *MYOCARDIAL infarction , *ATHEROSCLEROSIS , *LITERATURE reviews ,CARDIOVASCULAR disease related mortality - Abstract
This review summarizes the current literature and the open questions regarding the physiology and pathophysiology of the mechanical effects of heart rate on the vessel wall and the associated molecular signaling that may have implications for patient care. Epidemiological evidence shows that resting heart rate is associated with cardiovascular morbidity and mortality in the general population and in patients with cardiovascular disease. As a consequence, increased resting heart rate has emerged as an independent risk factor both in primary prevention and in patients with hypertension, coronary artery disease, and myocardial infarction. Experimental and clinical data suggest that sustained elevation of heart rate—independent of the underlying trigger—contributes to the pathogenesis of vascular disease. In animal studies, accelerated heart rate is associated with cellular signaling events leading to vascular oxidative stress, endothelial dysfunction, and acceleration of atherogenesis. The underlying mechanisms are only partially understood and appear to involve alterations of mechanic properties such as reduction of vascular compliance. Clinical studies reported a positive correlation between increased resting heart rate and circulating markers of inflammation. In patients with coronary heart disease, increased resting heart rate may influence the clinical course of atherosclerotic disease by facilitation of plaque disruption and progression of coronary atherosclerosis. While a benefit of pharmacological or interventional heart rate reduction on different vascular outcomes was observed in experimental studies, prospective clinical data are limited, and prospective evidence determining whether modulation of heart rate can reduce cardiovascular events in different patient populations is needed. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.